Courtois-Cox S, Jones S L, Cichowski K
Genetics Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 2115, USA.
Oncogene. 2008 May 1;27(20):2801-9. doi: 10.1038/sj.onc.1210950. Epub 2008 Jan 14.
Oncogene-induced senescence is a mechanism of tumor suppression that restricts the progression of benign tumors. Important advances have been made toward elucidating the mechanisms that regulate this response; however, there is presently no unified model that integrates all current findings. DNA damage, replicative stress, reactive oxygen species, heterochromatin formation and negative feedback signaling networks have all been proposed to play an integral role in promoting senescence in response to various oncogenic insults. In all cases, these signals have been shown to function through Rb and p53, but utilize different intermediaries. Thus, it appears that senescence is not triggered by a single, linear series of events, but instead is regulated by a complex signaling network. Accordingly, multiple proteins may cooperate to establish a senescence response, but the limiting signal(s) may be dictated by the initiating genetic alteration and/or tissue type. This review will focus on integrating current models and will highlight data that provide new insight into the signals that function to suppress human tumor development.
癌基因诱导的衰老(Oncogene-induced senescence)是一种肿瘤抑制机制,可限制良性肿瘤的进展。在阐明调节这种反应的机制方面已经取得了重要进展;然而,目前还没有一个统一的模型能够整合所有当前的研究结果。DNA损伤、复制应激、活性氧、异染色质形成和负反馈信号网络都被认为在响应各种致癌性损伤时促进衰老过程中发挥着不可或缺的作用。在所有情况下,这些信号都已被证明通过Rb和p53发挥作用,但利用了不同的中间介质。因此,衰老似乎不是由单一的线性事件序列触发的,而是由一个复杂的信号网络调节的。相应地,多种蛋白质可能协同建立衰老反应,但限制信号可能由起始基因改变和/或组织类型决定。本综述将专注于整合当前模型,并突出那些为抑制人类肿瘤发展的信号提供新见解的数据。